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ABSTRACT A computational docking strategy using multiple conformations of the target protein is discussed and evaluated.
A series of low molecular weight, competitive, nonpeptide protein tyrosine phosphatase inhibitors are considered for which the
x-ray crystallographic structures in complex with protein tyrosine phosphatase 1B (PTP1B) are known. To obtain a quantitative
measure of the impact of conformational changes induced by the inhibitors, these were docked to the active site region of
various structures of PTP1B using the docking program FlexX. Firstly, the inhibitors were docked to a PTP1B crystal structure
cocrystallized with a hexapeptide. The estimated binding energies for various docking modes as well as the RMS differences
between the docked compounds and the crystallographic structure were calculated. In this scenario the estimated binding
energies were not predictive inasmuch as docking modes with low estimated binding energies corresponded to relatively large
RMS differences when aligned with the corresponding crystal structure. Secondly, the inhibitors were docked to their parent
protein structures in which they were cocrystallized. In this case, there was a good correlation between low predicted binding
energy and a correct docking mode. Thirdly, to improve the predictability of the docking procedure in the general case, where
only a single target protein structure is known, we evaluate an approach which takes possible protein side-chain conformational
changes into account. Here, side chains exposed to the active site were considered in their allowed rotamer conformations and
protein models containing all possible combinations of side-chain rotamers were generated. To evaluate which of these
modeled active sites is the most likely binding site conformation for a certain inhibitor, the inhibitors were docked against all
active site models. The receptor rotamer model corresponding to the lowest estimated binding energy is taken as the top
candidate. Using this protocol, correct inhibitor binding modes could successfully be discriminated from proposed incorrect
binding modes. Moreover, the ranking of the estimated ligand binding energies was in good agreement with experimentally
observed binding afﬁnities.
INTRODUCTION
Rational structure-based ligand design is becoming more
important as an increasing number of three-dimensional
structures of biological targets become available. An es-
sential element in the ligand design process is to predict
reliable binding afﬁnities for candidate ligands. This is im-
portant for at least two reasons. Firstly, it provides a means to
score compounds and screen virtual compound libraries in an
attempt to enhance the selection of those members, which are
most likely to be active against the target of interest,
and hence reduce the number of compounds to synthesize.
Secondly, it can yield valuable insight into the binding de-
terminants for the complex of interest. In a practical ligand
design process, computational docking tools are applied to
predict ligand binding modes as well as associated binding
afﬁnities. In that respect, low energy binding modes should
resemble the experimentally observed binding mode. Other-
wise, there are no well-established objective criteria to dis-
criminate between a correct or incorrect docking mode.
During the last decades docking methods have received
much attention from the scientiﬁc community. However,
estimating reliable ligand binding afﬁnities and ligand bind-
ing modes is a very challenging task. At least two fundamen-
tal prerequisites are required: 1), a reliable scoring function,
and 2), a proper treatment of ligand and protein ﬂexibility
to account for induced changes in the conformation of the
protein target and the ligand itself. Most docking methods
are based on fairly general scoring functions to make them
applicable for a wide range of systems. To reduce the degree
of freedom and the size of the problem, early docking pro-
cedures treated both the ligand and the protein as rigid bodies
(Kuntz et al., 1982; Sobolev et al., 1996). To improve the
docking procedures, most docking approaches take ligand
ﬂexibility into account but treat the protein target as rigid
(Rarey et al., 1996; Makino and Kuntz, 1998; Sobolev
et al., 1996, 1997; Baxter et al., 1998; Oshiro et al., 1995).
Docking simulations with a ﬂexible target are currently
not attractive given the need to obtain results for a single
ligand within minutes.
Docking studies in our laboratory using different docking
approaches showed that more reliable results could be ob-
tained, when ligands (cocrystallized with a given protein) are
docked back into their parent protein structures. Due to the
effect of induced ﬁt the docking methods were generally less
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successful when a ligand from one complex is docked to
a protein-binding site derived from a complex with another
ligand. This was observed to be the case, even for closely
related ligands with equally good binding afﬁnities, where
small shifts in atomic positions in the binding site are in-
duced from one ligand to the other. This suggests that one
single conformation of the protein-binding site may not be
sufﬁcient to address the diversity of possible binding modes
induced by different ligands. Consequently, a rigid protein-
binding site can lead to errors in the identiﬁcation of the
correct binding mode and the assessment of reliable bind-
ing afﬁnities.
Ligand binding can involve a wide range of induced
conformational changes in the protein, such as loop or
domain movements. However, in most cases changes in the
protein backbone structure are negligible and in 85% of the
ligand-protein complexes in the protein databank only a small
number of side chains (three or less) undergo conformational
changes upon ligand binding (Najmanovich et al., 2000).
The root mean square displacement (RMSD) between
corresponding Ca atoms deviated less than 2 A˚ in 88%
and less than 1 A˚ in 75% of the cases. It is important to note
that main-chain conformational changes between a protein in
complex with different ligands in general has a lower RMSD
as compared to the side-chain RMSD of the corresponding
complexes. This suggests that ligand-induced conforma-
tional changes are more pronounced for side chains as
compared to main-chain conformational changes. In many
cases, the changes involve rotamer differences in protein side
chains which often have x1 close to the {t, g(1), g()}
symmetry values of 1808, 608, and –608 degrees. Therefore
combinatorial approaches applying statistical information of
conformational side-chain preferences may be very efﬁcient.
The present study addresses a computational problem often
encountered in the early phase of a drug discovery project.
The fundamental question is how one can account for the
diversity of binding modes induced by various ligands. The
goal is to enhance the correct prediction of binding mode and
binding afﬁnity of possible drug candidates, when only one
single structure of the protein target is available. Here, we
demonstrate the application of a simple docking strategy. Our
approach is based on producing various models using one
single structure of the target protein and statistical information
of side-chain conformational preferences. More precisely,
x-dihedral angles of the side chains in question are assigned
discrete values from a main chain dependent rotamer library
such that all possible combinations of the different rotamer
states are represented. To evaluate our approach, we have
used the x-ray crystallographic structure of human protein
tyrosine phosphatase 1B (PTP1B) solved in complex with
a hexapeptide (Protein Data Bank; entry code 1ptu) as a test
case (Bernstein et al., 1997, Jia et al., 1995). We have chosen
PTP1B inasmuch as it has recently received much attention
due to its proposed role as a negative regulator of insulin
signaling (Møller et al., 1995; Ide et al., 1994; Boylan et al.,
1992; McGuire et al., 1991), and hence there exists a great
interest in designing selective inhibitors for this enzyme.
Inspection of this x-ray structure reveals that a few side chains
ﬂanking the active site region are important for substrate
recognition. Here, we focus on the side chains of Asp48,
Lys120, Asp181, and Phe182 and study the inﬂuence of
conformational changes of these side chains on the binding
behavior of different ligands. As we will demonstrate in the
Results and Discussion section, relatively small structural
changes restricted to side chains can have a signiﬁcant impact
on binding afﬁnities predicted by computational docking
tools.
METHODS
The reference structure
The high resolution x-ray crystallographic structure of PTP1B solved in
complex with a hexapeptide DADEpYL-NH2 (pY stands for phosphorylated
tyrosine) (Jia et al., 1995) was obtained from the Protein Data Bank
(Bernstein et al., 1997, entry code: 1tpu). In the following this structure is
referred to as the reference structure, inasmuch as it is used for comparisons
and serves as a template structure for all protein models produced by the
rotamer approach. To evaluate the rotamer approach as well as the quality of
the produced receptor models, three other PTP1B structures (Andersen et al.,
2000; Iversen et al., 2000; pdb entry codes: 1c85, 1c87, and 1c88) solved in
complex with the inhibitors 1, 2, and 3 shown in Fig. 1, were included. These
structures were only used for comparison and evaluation of the approach.
The PTP1B structures were superimposed onto the reference structure. The
resulting positions of the superimposed inhibitors were used to measure the
RMS differences to those predicted by FlexX (see Table 1).
Crystallographic water molecules
All crystal water molecules were removed from the reference structure with
the exception of a single well-deﬁned buried water molecule located in the
binding pocket between the main chain NH of Phe182 and the scissile
oxygen of pY. This water molecule (W 304) has been observed in all x-ray
crystallographic structures of PTP1B in complex with different ligands.
Generally, the role of crystallographically identiﬁed water molecules is
difﬁcult to interpret. Clearly, they may play an important role in the drug
design process—in particular, when ligands are modiﬁed in a way that could
lead to either the creation or removal of cavities large enough to
accommodate water. In the present study we kept the well-deﬁned active
site water molecule, because it is involved in the catalytic process and
interacts with the protein via well-deﬁned hydrogen bonds.
Preparation of protein models
Amino acid side chains are known to adopt discrete conformations (rota-
mers) depending on the local protein environment (Petrella et al., 1998).
FIGURE 1 Chemical structures of inhibitors used in the docking experi-
ments.
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Side chains exposed to the active site are assigned discrete conforma-
tions obtained from a main chain conformation dependent rotamer library
such that all possible combinations of the rotamer states are represented.
The four side chains considered in this study are Asp48, Lys120, Asp181,
and Phe182 (see Fig. 2).
An analysis of a main chain torsional angle dependent rotamer library
within QUANTA (Accelrys Inc., San Diego) reveals that Phe182, Lys120,
and Asp48 can adopt 3, 4, and 8 rotamer states, respectively. For Asp181
only one rotamer identical with the one observed in the 1ptu x-ray structure
was populated. Thus a total of 33 43 8¼ 96 different protein models were
generated using the reference structure as a template. The 96 protein rotamer
models are all identical except for the conformations of the three side
chains Phe182, Lys120, and Asp48. In Fig. 2, the 96 models have been
superimposed. The majority of the proposed rotamer modes could be dis-
carded based on close contact arising when all possible combinations of the
rotamer states for the selected side chains are modeled. To identify such
models we simply computed the potential energy for each rotamer model
after it was energy-minimized in 20 steps steepest descent minimization
including all atoms using CHARMM (Brooks et al., 1983). The objective of
the minimization procedure was not to relax the receptor models as such, but
rather to obtain a potential energy for later comparison and evaluation. Two
of the rotamer conformations of Lys120 had serious clashes with other side
chains in the binding pocket. The other half of the models had acceptable
conformations.
pKa calculations
There are three charged residues in the binding pocket of PTP1B, which
have been indicated to interact with a bound inhibitor. These are two Asp
(48, 181) and one Lys (120) side chain. One of the questions is if the
protonation state of these residues is affected by the presence of the ligand.
To estimate this effect due to inhibitor binding, we used the multisite
titration model introduced by Schaefer and Karplus (Schaefer et al., 1997) to
calculate the ionization state of the three residues Asp48, Lys120, and
Asp181. The calculations were performed in absence and in the presence of
the inhibitor. Hydrogens were added using CHARMM and the protein atoms
were assigned partial charges and radii from the CHARMM22 force ﬁeld. A
probe radius of 1.4 A˚ was used for molecular surface calculations. For the
interior dielectric constant, we used e ¼ 20 as suggested by Antosiewicz
et al. (1996) and the solvent dielectric constant was set to e ¼ 80. The ionic
strength was set to 0.145 M with the ion density after a Boltzmann
distribution at 300 K. Initially the potential was calculated on a 2 A˚ grid, and
the so-called focusing technique was applied for a more accurate evaluation
of the potential around the ionization sites by subsequently reducing the grid
size to 1.4 A˚, 0.7 A˚, and 0.35 A˚.
Formal charges were assigned to the ligands. The pKa of the oxalylamide
in compounds 1–3 is 2–2.5, whereas the pKa of the other carboxylate in the
compounds is close to 4. Therefore the oxygens of these carboxylates were
assigned a charge of 1/2. As discussed below, the three ionizable side
chains are estimated to be fully charged in the absence and the presence of
the inhibitors at physiological pH.
FlexX docking
In this study we applied the FlexX docking program (Rarey et al., 1996),
which uses an efﬁcient incremental construction method (Leach and Kuntz,
1992) to optimize the interaction between a ﬂexible ligand and a rigid
binding site. In this methodology, an empirically derived scoring function,
which is optimized to reproduce experimental binding afﬁnities and binding
conformations for various crystallographic resolved protein/ligand com-
plexes, is used to predict the free energy of binding (DGbind). In all docking
experiments presented in this study a scoring function with default
parameters was used.
RESULTS AND DISCUSSION
The paper is outlined as follows. After describing the results
from the pKa calculations the docking experiments are
presented. Firstly, the set of inhibitors are docked to the
structure of PTP1B originally solved in complex with the
hexapeptide DADEpYL-NH2 (pdb entry code: 1ptu) and the
parent structures (i.e., the structures of PTP1B solved in
complex with the corresponding inhibitor; pdb entry codes:
1c85, 1c87, and 1c88). Secondly, the inhibitors are docked to
the protein models produced by the rotamer approach.
Thirdly, the best protein models (i.e., those which obtained
the best free energy of binding in the FlexX docking
procedure for each inhibitor) are compared to the experi-
mental structure solved in complex with the inhibitor in
question.
pKa calculations
The titration curves for the ionizable active site residues
Asp48, Lys120, and Asp181 are shown in Fig. 3. The curves
with solid and open symbols are obtained for the enzyme in
complex with an absence of an inhibitor, respectively. The
pKa values in the absence of the inhibitor are calculated to
0.8, 12.3, and 1.4 respectively, whereas the calculated pKa
TABLE 1
RMS to 1PTU
PDB entry code
RMS (A˚) of heavy atoms
to the reference structure
RMS (A˚) of side chains
to the reference structure
1c85 0.37 0.67
1c87 0.23 0.95
1c88 0.37 0.94
RMS difference between the x-ray crystallographic structures (pdb entry
codes: 1c85, 1c87 and 1c88) and the reference structure (pdb entry code:
1ptu).
FIGURE 2 Superposition of the 96 models used for docking.
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values for Asp48, Lys120, and Asp181 in the presence of the
inhibitor are 1.6, 14.2, and 3.7. It is not surprising that the
presence of the inhibitors increases the pKa, because the
inhibitor itself is negatively charged. Our results indicate that
the three side chains investigated are charged in the presence
as well as absence of the inhibitors at physiological pH.
Hence, in the docking experiments the three side chains are
charged.
Docking of the ligands to their parent structures
To illustrate the shortcoming of the simplest docking exper-
iment, we ﬁrst discuss the results obtained from docking of
each of the three inhibitors to their parent structures and
additionally to the protein structures cocrystallized with the
other inhibitors (‘‘cross-docking’’). The results of the
docking experiment are shown in Table 2, together with
the experimentally determined inhibition constants. The
results are quantiﬁed in terms of the lowest estimated free
energy of binding and the RMS difference between the
predicted binding conformation and the experimental
binding mode (number in parenthesis). As seen from the
results in the diagonal, the docking procedure successfully
identiﬁes the correct binding mode as the lowest energy
conﬁguration, when the protein structure is derived from the
complex with the inhibitor itself. Nevertheless, the docking
procedure is less successful when the inhibitors are docked
against the protein structures derived from complexes
obtained with other inhibitors as seen from the off-diagonal
results in Table 2. The cross-docking experiment shows that
the assumption of a rigid protein cavity can lead to errors not
only in the predicted binding afﬁnities but also in the
predicted binding modes of the inhibitors. To overcome this
shortcoming, we investigate in the following a combination
of FlexX and multiple protein targets produced by the
rotamer approach.
Docking of ligands to the reference structure
In this section we present the docking results for each of the
inhibitors obtained for the reference structure. Recall that this
structure was chosen inasmuch as it has never seen the
nonpeptide inhibitor and consequently, the geometry of the
binding site is adapted to the bound hexapeptide. The 15 best
scoring docked solutions (in terms of estimated free energy
of binding) for each of the inhibitors 1, 2, and 3 are shown in
Fig. 4, A–C as functions of the RMS difference between the
experimental and the predicted binding modes. There is no
correlation between low predicted free energy of binding
(DGbind) and low RMS for any of the inhibitors. For
example, the lowest DGbind for compound 3 is;27 kJ/mol
(Fig. 4C), but the RMS difference between the predicted and
the experimentally observed binding mode is 20 A˚. On the
other hand, the docking mode having the lowest RMSD (2.3
A˚), when compared to the experimental observed binding
mode, has a predicted DGbind of 25 kJ/mol; i.e., 2 kJ/mol
larger compared to the docking mode of the lowest energy of
binding. Similar results are obtained for compound 2 shown
in Fig. 4 B. Here, the binding mode with the lowest predicted
DGbind (;31 kJ/mol) has an RMS difference of 4 A˚
compared to the experimentally observed binding mode. For
compound 1 all of the 15 best scored docking modes have
relatively large RMS deviations[8 A˚ and the predicted free
energies of binding are all within a narrow range between
;23.0 kJ/mol and 19.5 kJ/mol (Fig. 4 A). In this case,
the inhibitor complex with the lowest free energy of binding
has a RMS deviation of 8 A˚, when compared to the
experimentally observed binding mode. In all three cases, the
complexes based on the reference structure poorly predict the
correct ligand binding mode, even though the differences
between the crystal structures mainly are restricted to
conformational changes of a few side chains. Hence, the
predicted DGbind could not be used to discriminate between
a correct or an incorrect binding mode.
FIGURE 3 Calculated titration curves. Open squares, circles, and
triangles represent the calculated titration curves for Asp48, Lys120, and
Asp181, respectively, in absence of the inhibitor. The titration curves in
presence of the inhibitor are represented with solid symbols.
TABLE 2
X-ray
structure/
compounds
1c85
[kJ/mol]
1c87
[kJ/mol]
1c88
[kJ/mol]
1ptu
[kJ/mol]
Exp. Ki
[mM]
1 32.8 (1.1) 19.8 (13.5) 33.7 (8.7) 23.0 (17.6) 200
2 24.4 (8.5) 34.5 (0.9) 31.2 (0.8) 30.9 (3.9) 63
3 26.4 (8.7) 27.5 (0.8) 37.0 (1.2) 27.0 (20.3) 4
Results of docking inhibitors 1, 2, and 3 to their parent PTP1B crystal
structures (to which they were cocrystallized) shown in bold as well as to
the structures cocrystallized with the other inhibitors. The predicted free
energies of binding DG are in [kJ/mol]. The RMS (A˚) differences between
the experimental and predicted ligand binding modes are given in
parentheses.
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FIGURE 4 FlexX docking results obtained against the reference structure.
(A) The 15 lowest predicted free energies of binding [kJ/mol] of inhibitor 1
versus the RMS difference (A˚). The difference is calculated between the
docked and the experimentally observed ligand binding conformation.B and
C show the results obtained for the inhibitors 2 and 3, respectively.
FIGURE 5 Results obtained from FlexX docking experiments against the
96 models of the PTP1B binding site. (A) Lowest free energy of binding [kJ/
mol] of inhibitor 1 to each of the 96 protein models as function of the RMS
difference between the docked and the experimentally observed binding
mode. B and C show the results obtained for the inhibitors 2 and 3,
respectively.
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In the following we apply the rotamer approach to side
chains exposed to the active site of the reference structure.
The objective is to test the robustness of the rotamer
approach, i.e., to examine if a single protein structure can be
modiﬁed to recognize the inhibitors 1, 2, and 3, resulting in
binding modes and estimated afﬁnities, which match
experimental ﬁndings.
Docking compounds against 96 protein models
The docking results for each of the inhibitors 1, 2, and 3 to
each of the 96 PTP1B models produced from the reference
structure using the rotamer approach are presented below.
The single best docking mode of lowest predicted free
energy of binding obtained for each of the inhibitors 1, 2, and
3 against the 96 PTP1B models are shown in Fig. 5, A–C as
functions of the RMS differences between the experimen-
tally observed and the predicted binding modes. The lowest
DGbind values obtained among all PTP1B models for each
of the compounds 1, 2, and 3 are 32.8, 34.5, and 37.0
kJ/mol, respectively, and correspond to the binding modes
which have low RMS differences when compared to the
experimentally observed binding modes. More importantly,
in all cases these DGbind values are signiﬁcantly improved
when compared to the docking results obtained by using the
reference structure. Furthermore, the ranking of the esti-
mated binding energies of the inhibitors correlate with the
experimentally determined binding afﬁnities (Table 2). This
correlation is not unexpected, inasmuch as FlexX is based on
a scoring function, which has been derived from ﬁtting
experimental data (binding constants, binding modes, etc.;
Rarey et al., 1996). Hence, the scoring function indirectly
includes the contribution from the unbounded state. Of
course, this contribution is only exactly true for the set of
ligands used in deriving the scoring function. It is difﬁcult to
estimate an absolute value for the contribution of the un-
bounded state of our inhibitors, but the excellent agree-
ment between predicted binding modes and experimentally
observed binding modes suggests that the scoring function
also represents the class of inhibitors used in our study.
For compounds 1 and 3 (Fig. 5, A and C), the docking
modes, which are in best agreement with experiments, also
have the lowest free energy of binding. The complex with
lowest estimated binding energy for compound 2 has a RMS
value of ;1 A˚ when compared to the experimentally ob-
served binding mode. The docking modes with the second
and third lowest predicted free energy of binding have
slightly lower RMS values being close to 0.75 A˚. However,
we consider these docked modes to be equally good and the
best solution (in terms of energy) has a signiﬁcantly lower
DGbind of ;5 kJ/mol compared to the docked conformation
with a slightly lower RMS.
To further validate the liability of the docking procedure,
we docked inhibitors 1, 2, and 3 against the rotamer models,
which resulted in the overall lowest binding energy ac-
cording to the results in Fig. 5. Again, the 15 best scored
docking modes for the three inhibitors against the best
protein model are shown in Fig. 6, A–C as a function of
FIGURE 6 Solutions obtained by docking compounds 1, 2, or 3 to the
protein model, which has the best score according to the results in Fig. 5.
(A) The 15 best scored complexes [kJ/mol] for compound 1 versus the RMS
difference (A˚). B and C show the results obtained for the inhibitors 2 and 3,
respectively.
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the RMS differences between the experimental observed and
the predicted binding mode. So in contrast to the results
presented in Fig. 5, the results in Fig. 6, A–C originate from
one protein model. Signiﬁcantly better results were obtained
than in the docking procedure using the reference structure
(see Fig. 4).
An interesting question is to what extent the three best
rotamer models agree with the experimentally resolved x-ray
structures of PTP1B in complex with inhibitors 1, 2, or 3. To
investigate this, we superimposed the x-ray structures of
PTP1B in complex with the compounds 1, 2, and 3 with the
three best PTP1B rotamer models, deduced from Fig. 5. The
superimposed structures are displayed in Fig. 7. Side-chain
conformations of the best rotamer model and the corre-
sponding predicted ligand binding mode are shown in gray.
The crystal structures in complex with the compounds are
shown in green, and side-chain conformations of the
reference structure are shown in red.
As shown in Fig. 7 A, the side-chain conformations of
Phe182 and Lys120 of the protein model, which correspond
to the lowest predicted DGbind, agree well with the x-ray
crystallographic structure. The Asp48 side-chain conforma-
tion differs by being more exposed to the solvent. The
second best model (not shown) for compound 1 has similar
Asp48 and Lys120 side-chain conformations as in the
experimental structure, but the benzene ring of Phe182 is
rotated almost 408 from the conformation in the experimental
structure. The best predicted binding mode (obtained among
the 96 rotamer models) for inhibitor 2 is compared to the
experimental structure in Fig. 7 B. Again, good agreement is
found between the predicted Phe182 and Lys120 side-chain
conformations and the experimentally observed conforma-
tions. In all the top ﬁve best models, Phe182 and Lys120
have the same conformations, whereas Asp48 in all cases
are more or less exposed to solvent. Having Asp48 in
a conformation identical to the one observed in the reference
structure (shown in red) is prohibited due to unfavorable
interactions with the pyran oxygen of the inhibitor (Iversen
et al., 2000). Finally, in the case of compound 3, the side-
chain conformations of Phe182, Lys120, and Asp48 are
nearly identical to the experimentally observed conforma-
tions (Fig. 7 C). In the ﬁve best models, Asp48 adopts a
conformation identical to the reference structure, inasmuch
as the carboxylate of this side chain forms a salt bridge
interaction with the basic nitrogen in compound 3, which is
in good agreement with the experimental conformation
(Iversen et al., 2000).
Finally, we calculated the potential energies of the 96
PTP1B models (in the absence of the compounds) and show
FIGURE 7 Comparison of x-ray crystallographic structures and docked
modes obtained for the best PTP1B models. A–C show the structures of
inhibitors 1, 2, and 3, respectively in complex with PTP1B. Side-chain
conformations of the best PTP1B models and the corresponding docked
inhibitor are shown in gray. The crystal structures in complex with the
compounds are shown in green, and the reference side-chain conformations
are shown in red.
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those as a function of the side-chain RMS difference between
predicted and the experimental structures in Fig. 8. This was
undertaken to identify rotamer models with minor protein
clashes and to elucidate if the rotamer models, which rec-
ognized the inhibitors 1, 2, and 3 with the best afﬁnity, were
among the models of low potential energy. It is impor-
tant to emphasize that the models only have been minimized
for a few steps as described in the Methods section. The
potential energies of the PTP1B rotamer models are within
the energy range of ;4900 to 4600 kcal/mol. The 96
models cluster into different regions with respect to potential
energy. Models with low potential energy are generally
closer to the experimental structures as shown in Fig. 8. The
circles indicate the ﬁve models, which were predicted to
have the best (i.e., lowest) DGbind. In all cases, the ﬁve best
ranked protein models belong to the cluster of lowest
potential energy. Rotamer models with signiﬁcant protein
clashes should of course be discarded in the ﬁrst step and not
be considered in the docking procedure. However, we used
all rotamer models in this study to ensure that the inhibitors
would recognize feasible models, i.e., low energy protein
models.
CONCLUSION
In this study we have presented and evaluated a computa-
tional docking strategy, which applies multiple conforma-
tions of the protein target. Using this approach, signiﬁcantly
improved results could be obtained compared to the case
where only one single conformation of the target protein is
used. We have shown that a single conformation of the
ligand binding site is not likely to be sufﬁcient to address
the diversity of possible binding modes. Docking of the
inhibitors to the PTP1B structures in which they were co-
crystallized yield good results (Fig. 4). In this case, FlexX
reproduced the experimental binding conformation, and the
associated predicted DGbind are qualitatively in agreement
with experiments. However, poor results were obtained
when the compounds were docked to x-ray structures of
PTP1B solved in complex with the other compounds. Thus
even small steric clashes may signiﬁcantly penalize a correct
docking mode resulting in an underestimation of DGbind.
Consequently, the estimated binding energies in this scenario
are not predictive and the docking modes with low estimated
binding energies do not correspond to the experimentally
observed binding modes. Signiﬁcantly improved binding
conformations and DGbind values were obtained when the
compounds were docked against a number of protein
models. The rotamer approach described here has the ad-
vantage of being computationally fast and protein models
can be generated within minutes. Inasmuch as the approach
is based on conformational side-chain preferences obtained
from a main-chain dependent rotamer library, it is expected
that this strategy is generally applicable to account for con-
formational changes of side chains. In a lead optimization
process, where small changes in the ligand may induce
structural changes in the binding cavity, our approach has the
potential of revealing the correct binding mode and may
reduce the number of false-negative predictions.
FIGURE 8 Comparison of the potential energies of the various PTP1B
protein models as a function of the RMS differences to the x-ray structures in
complex with the inhibitors. A, B, and C are for the inhibitors 1, 2, and 3,
respectively. The open circles indicate the ﬁve models, which were predicted
to have the best (i.e., lowest) binding energy.
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